Managing Diabetes Mellitus In Indigenous Communities: Clinical Practice Guidelines

Prevalence of Diabetes Mellitus in Indigenous communities

Discuss about the Diabetes Mellitus Education for Management.

The following educational program aims to educate indigenous Australians for the management of Diabetes Mellitus. Despite diabetes being a common disease among people of all ages and occupations it is unique in the sense that every patient requires a type care that is consistent with their type of disease and responds to different care and medication. Gone is the age when the disease was considered a reserve of the old and obese (Barnett, Kumar, Brinkløv, Thorsen, & Langberg, 2013). The prevalence of the disease is undiscriminating of age, gender, or body stature. Thanks to new technology and an enhancement in research about the disease, however, optimal care for diabetes is possible (Hollekim-Strand, Ingul, & Revdal, 2016). Purpose statement: The following essay looks at the steps that are taken to take care of Diabetes patients. The essay draws a parallel between the types of Diabetes and their care, defining in retrospect the aspect of optimal care for the disease as well as on-going research in Australia about ways of managing the disease better (King & Herman, 1998). The essay examines the roles of the different stakeholders in the care and treatment of diabetes as well as develops recommendations for contributions to be made to better the care and treatment of the disease.

The indigenous people of Australia are the primary focus of the following educational activity program. The population Bureau of Australia places Indigenous Australians at 3.3% of the entire Australian population. The population has increased from 3% in the year 2011. Most of the indigenous Australians identify as being of Torres Strait Islander or Aboriginal origin. The diverse Australian population faces various health challenges including the prevalence of Diabetes Mellitus. The population is recognized by the Australian National Health Priority Areas or the NHPA as a disadvantaged community. Australian National Health Priority Areas prioritizes rural communities, indigenous communities and the economically and socially disadvantaged. Diabetes is a metabolic disease that associated with high level of sugar in the blood over a prolonged period. The disease has its ultimate origin from the improper functionality of the pancreatic gland that is charged with the responsibility of producing insulin to help regulate the amounts and rates of blood sugar in the body system (Lauren A. Baldassarre, et al., 2016). For a long time is assumed diseases for the older people. However, this narrative has seemed to change with the disease now known to be present even among children as young as five years of age. The condition is very much accustomed with specific symptoms such as frequent urination, increased rate, and intensity of thirst and most of all the growing rate of hunger among the casualties (Buzga et al. 2016). The disease can grow into an acute stage thus causing massive complication if not treated in time.

Types of Diabetes and their respective care

Using Clinical Practice Guidelines (CPGs) which involves evidence-based documents that help in facilitating the use of evidence in daily emerging nursing issues, a better strategy has thereby been proposed to help fight diabetes (Teo & Dokainish, 2017). The facilitation that has received immense support from the Canadian Diabetes Association has so far been hailed as a promising front in the management of diabetes. Through the clinical practice guideline, it is established that there can be an improved diagnosis, prognosis, and therapeutic recommendation for the care of individual suffering from diabetes (Elias-Smale, Günal, & Maas, 2015). In addition, there could be recommendations for the best measures to be taken in delaying the onset of diabetes among people at high risk of contracting the condition and further advancements to type Diabetes Mellitus.

Diabetes being a global disease-affecting people of different calibers, races, and ethnicities, it would have been much easier to assume that there is an international participation in the strategies aimed at controlling it (Samar, 2012). However, in the real situation and ideological framework of bringing up the clinical practice guideline to help in controlling and managing diabetes mellitus, just a few organizations had been involved (Oster NV, Welch V, Schild L, Gazmararian JA, Rask K, & C, 2006). Diabetes who horrors have been advancing every five years since 1992 has seen many health practitioners and clinical organizations worried about the appropriate course to take in attempts to curb its spread, effects, and advancement into other more severe stages.

The Department of Disease control in conjunction with the Australian Diabetes Association have come out to publish the comprehensive and evidence-based recommendation for the medical practitioners to be able to adhere to in their practices of preventing and managing diabetes (Mehta, Wei, & Wenger, 2015). The guidelines made through the collaboration of the US government departments and the Canadian agencies charged with medical services developed the mechanisms most especially for the Canadians and the US, however largely they are meant to serve internationally among diabetic patients (Buzg et al. 2016). In congruence with the service opinion, the guideline has until now been a helpful resource for nurses and doctors caring for people with diabetes.

Due to the extreme sensitivity of the issue at hand and the rate of need for such a course, there were several mechanisms put into place to ensure the smooth running and the eventual success of the of the medical practice guidelines (Xiao-Xu Xiea, et al., 2016). The need for adequate expertise saw the increase and expansion of the expert committee to about 120 heath care professionals and specialists who volunteered from various health sectors across Australia. The move was aimed at bringing additional expertise from a broad scope of medical practice settings so that the issue could be understood from the various angles to provide the easiest way to the solutions (Tony Barnett & Kumar, 2009). There was another addition to the committee to include the people suffering from the said disease so that their views and preferences regarding the necessary recommendations be taken into consideration.

Roles of different stakeholders in managing Diabetes

Figure 4 Types of Action for Type 2 DiabeteIn the elaboration of the guideline latter to be adopted for use in various medical institutions for the management and treatment of diabetes, several processes were followed. Each step in the instruction was taken from the clinically relevant question why the committee of experts related to the diagnosis, prognosis, treatment, and management of the disease and the expected implications (Elias-Smale, Günal, & Maas, 2015). The board members were to evaluate the society to which the guideline would apply with the intentions as to why the given population was chosen, thereby assuming the expected outcome from each population. With the pick of a particular population and estimating the possible outcome, the citations were then used to devise a recommendation with suitable evidence based on the specified criteria (Elias-Smale, Günal, & Maas, 2015). Several studies were then made in the various states and conditions of diabetes from the observation and diagnosis of different patients under consent relating it with the various prognoses they had already put down. The studies were as such important in developing and supporting each recommendation of the strategies of the medical procedures.

Diabetic people being diverse and heterogeneous group regarding race, age, sex and even social status, it is necessary that the treatment measures be made on individual patient’s capacities. Through the proposed guidelines, decisions are to be made dependent on the available evidence about the condition to be treated except in therapeutic conditions in which decisions are made depending on the relationship between the patient and the caregiver (Hollekim-Strand, Ingul, & Revdal, 2016). The proposed guideline any treatment as such must be evidence based to help outweigh the possible benefits or harm that a process may cause. It is also recommended that under severe circumstances the patient opinions should not be counted upon in decision making unless the situation requires the patient's consent for a process to be commenced (Lauren A. Baldassarre, et al., 2016).

For successful implementation of the proposed guidance, a dissemination and implementation were needed from the onset of the instruction. The practitioners of medical heath purposely cut for the Diabetic Mellitus control and management had been strategized on the healthy practices aimed at increasing their implementation of the guideline and thus improved the patient's care and the expected health outcomes (Mehta, Wei, & Wenger, 2015). A committee of experts was further appointed to help in driving the workability of the proposed practice through a strategic plan purpose to see its assimilation into the system in its fullness and as such, there were three-year volunteering experts from the different countries tasked with this goal.

Benefits and limitations of Clinical Practice Guidelines in Diabetes management

Diabetes is one of the contemporary society’s biggest problems that come with complexity and complications to an individual suffering from its conditions. The advancements in the new technologies have so far offered better ways through which caregivers in hospitals can take care of their patients thus reducing the risks that had initially come with its attack on its victims. Now with the advancement and the improvements on the guidelines in taking care of the patients, it is only hoped that the problem of diabetes will soon be a problem of the past. As much as several preparations had been in the underway awaiting the implementation of the clinical procedures, some setbacks could still be witnessed jostling the progressiveness of the system.  Cost is one significant issue still facing the full implementation of the proposed guideline with very many health practitioners and the patients fearing the costliness of the whole procedures. Editorial independence

References

Barnett, T., Kumar, S., Brinkløv, C. F., Thorsen, I. K., & Langberg, H. (2013). Criterion validity and reliability of a smartphone delivered sub-maximal fitness test for people with type 2 diabetes. BMC Sports Science, Medicine & Rehabilitation, 2(3), 1-120.

Elias-Smale, S., Günal, A., & Maas, A. (2015). Gynecardiology: Distinct patterns of ischemic heart disease in middle-aged women. Maturitas, 81(3), 348-352.

Hollekim-Strand, S. M., Ingul, C. B., & Revdal, A. (2016). Can Time Efficient Exercise Improve Cardiometabolic Risk Factors in Type 2 Diabetes? A Pilot Study. Journal of Sports Science & Medicine, 4(5), 1-120.

King, H. R., & Herman, W. (1998). Global Burden of Diabetes, 1995-2025. Prevalence, Numerical Estimates and Projections, 21(9), 1414-431.

Lauren A. Baldassarre, Subha V. Raman, James K. Min, Jennifer H. Mieres, Martha Gulati, Nanette K. Wenger, et al. (2016). Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease nursing. JACC: Cardiovascular Imaging, 9(4), 421-435.

Marek Buzga, Petra Maresova, Adela Seidlerova, Pavel Zonca, Pavol Holeczy, & Kuca, K. (2016). The influence of methods of bariatric surgery for treatment of type 2 diabetes mellitus. Therapeutic and Clinical Risk Management, 2016(12), 599-605.

Mehta, P., Wei, J., & Wenger, N. (2015). Ischemic heart disease in women: A focus on risk factors. Trends in Cardiovascular Medicine, 25(1), 140-151.

Oster NV, Welch V, Schild L, Gazmararian JA, Rask K, & C, S. (2006). Differences in Self Management Behaviours and Use of Preventive Services among Diabetes Management Enrollees by race and Ethnicity. Dis Manag, 9(3), 167-75.

Samar, B. (2012). Unconventional Organ Damage in Diabetes . New York : N.P .

Teo, K., & Dokainish, H. (2017, November ). The Emerging Epidemic of Cardiovascular Risk Factors and Atherosclerotic Disease in Developing Countries. Canadian Journal of Cardiology, pp. 358-365.

Tony Barnett, & Kumar, S. (2009). Obesity and Diabetes. New York: Wiley.

Xiao-Xu Xiea, Wei-Min Zhouc, Fang Lina, Xiao-Qing Lia, Wen-Ling Zhonga, Shu-Guang Lina, et al. (2016). Ischemic heart disease deaths, disability-adjusted life years and risk factors in Fujian, China during 1990–2013: Data from the Global Burden of Disease Study 2013. International Journal of Cardiology, 214(1), 265-269.